JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy-Reference-Cited by-同舟云学术

JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy

Published:2021-12-30 Issue:26 Volume:138 Page:2886-2889
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Gangat Naseema¹,Szuber Natasha²,Alkhateeb Hassan¹,Al-Kali Aref¹,Pardanani Animesh¹,Tefferi Ayalew¹

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; and

2. Department of Hematology, Université de Montréal, Montréal, QC, Canada

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/138/26/2886/1855982/bloodbld2021013996.pdf

Reference16 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood.,2016

2. Polycythemia vera: historical oversights, diagnostic details, and therapeutic views [published online ahead of print 3 September 2021];Tefferi;Leukemia.

3. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views;Gangat;Leukemia.,2021

4. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med.,2019

5. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med.,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the full blood count: Circulating blood cells and their role in coagulation;British Journal of Haematology;2024-08-07

2. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13

3. Being John Plasma Volumovich, pecularities of plasma volume estimation in patients with polycythemia vera;Thrombosis Research;2024-07

4. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

5. Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series;Turkish Journal of Hematology;2024-05-30